Be a part of
Breakthrough
Research

Canopy Clinical is currently accepting expressions of interest for several upcoming Type 2 Diabetes management studies

Canopy Clinical has launched a suite of weight-management related studies. Register your interest in participating today.

This clinical trial is investigating an experimental study drug (casdatifan) for people living with unresectable, locally advanced, or metastatic renal cell carcinoma with a primary clear cell component. The purpose of the study is to determine if the study drug improves patient outcomes compared to standard treatment.

This study is investigating a potential new treatment that aims to lower hypertension (blood pressure that is too high) when used alongside standard treatments.

This research study is investigating a new potential treatment for Venous Leg Ulcers (VLUs), a clear gel containing an experimental drug that is applied directly to the VLU; compared to a control placebo gel treatment.

Diabetic foot ulcers (DFUs) are a serious and common complication of diabetes, affecting millions of people worldwide. This study is investigating a potential topical treatment called CYWC628. The treatment aims to support wound healing by promoting tissue regeneration, reducing inflammation, and improving blood flow to the affected area.

This clinical research study is investigating a potential tropical treatment for mild to moderate toenail fungal infections (onychomycosis). Onychomycosis is a common chronic condition that causes thickening, discoloration, and damage to the toenails.

Migraine headaches are a common, debilitating medical condition, impacting more than 4.9 million Australians. This study is researching an investigational treatment for people living with migraine headaches who are between the ages of 18 and 65.

This is a research study investigating a potential new treatment for atherosclerosis, a chronic heart disease.

This study is investigating the use of a new medication that is a combination of two previously approved treatments for hypertension to target the CNS physiological stress system for patients with panic disorder.